Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Shares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Mainz Biomed (MYNZ) Shares Outstanding (Diluted Average) (2020 - 2025)

Mainz Biomed's Shares Outstanding (Diluted Average) history spans 3 years, with the latest figure at $14.2 million for Q4 2022.

  • For Q4 2022, Shares Outstanding (Diluted Average) rose 96.33% year-over-year to $14.2 million; the TTM value through Dec 2022 reached $14.2 million, up 96.33%, while the annual FY2022 figure was $14.2 million, 96.33% up from the prior year.
  • Shares Outstanding (Diluted Average) for Q4 2022 was $14.2 million at Mainz Biomed, up from $7.2 million in the prior quarter.
  • Across five years, Shares Outstanding (Diluted Average) topped out at $14.2 million in Q4 2022 and bottomed at $5.6 million in Q4 2020.
  • The 3-year median for Shares Outstanding (Diluted Average) is $7.2 million (2021), against an average of $9.0 million.
  • The largest annual shift saw Shares Outstanding (Diluted Average) grew 28.6% in 2021 before it surged 96.33% in 2022.
  • A 3-year view of Shares Outstanding (Diluted Average) shows it stood at $5.6 million in 2020, then grew by 28.6% to $7.2 million in 2021, then soared by 96.33% to $14.2 million in 2022.
  • Per Business Quant, the three most recent readings for MYNZ's Shares Outstanding (Diluted Average) are $14.2 million (Q4 2022), $7.2 million (Q4 2021), and $5.6 million (Q4 2020).